BioCentury | May 21, 2019
Company News

May 21 Company Quick Takes: Verily in deal with pharmas; plus Amryt-Aegerion, Prokaryotics

...Amryt already holds territorial rights to the latter drug. Prokaryotics gets rights to Fundación Medina's antibiotics Fundación Medina...
...will be eligible for royalties; financial terms were not disclosed. Chris Lieu, Staff Writer Alphabet Inc. Amryt Pharma plc Fundación Medina Novartis...
BioCentury | Mar 9, 2015
Company News

Fundacion Medina, Cyclenium Pharma deal

...of Granada. Cyclenium declined to disclose financial details, and Medina did not respond to inquiries. Fundacion Medina...
BioCentury | Jun 18, 2012
Company News

Cubist, Fundacion Medina deal

...N.J.), the Andalucia government and the University of Granada. Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Fundacion Medina...
BioCentury | Jun 18, 2012
Finance

Highlights of weekly biotech stock moves

...2017, up from $698.8 million in 2011 (see B8) . Separately, Cubist partnered with not-for-profit Fundacion Medina...
BioCentury | Jun 12, 2012
Company News

Cubist outlines five-year strategy

...opioid-induced constipation; and CB-183,315 for Clostridium difficile -associated diarrhea (CDAD). Separately, Cubist partnered with not-for-profit Fundacion Medina...
BioCentury | Nov 21, 2011
Company News

Ferrer, Fundacion Medina deal

...the University of Granada. Details were not disclosed. Grupo Ferrer Internacional S.A. , Barcelona, Spain Fundacion Medina...
Items per page:
1 - 6 of 6
BioCentury | May 21, 2019
Company News

May 21 Company Quick Takes: Verily in deal with pharmas; plus Amryt-Aegerion, Prokaryotics

...Amryt already holds territorial rights to the latter drug. Prokaryotics gets rights to Fundación Medina's antibiotics Fundación Medina...
...will be eligible for royalties; financial terms were not disclosed. Chris Lieu, Staff Writer Alphabet Inc. Amryt Pharma plc Fundación Medina Novartis...
BioCentury | Mar 9, 2015
Company News

Fundacion Medina, Cyclenium Pharma deal

...of Granada. Cyclenium declined to disclose financial details, and Medina did not respond to inquiries. Fundacion Medina...
BioCentury | Jun 18, 2012
Company News

Cubist, Fundacion Medina deal

...N.J.), the Andalucia government and the University of Granada. Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Fundacion Medina...
BioCentury | Jun 18, 2012
Finance

Highlights of weekly biotech stock moves

...2017, up from $698.8 million in 2011 (see B8) . Separately, Cubist partnered with not-for-profit Fundacion Medina...
BioCentury | Jun 12, 2012
Company News

Cubist outlines five-year strategy

...opioid-induced constipation; and CB-183,315 for Clostridium difficile -associated diarrhea (CDAD). Separately, Cubist partnered with not-for-profit Fundacion Medina...
BioCentury | Nov 21, 2011
Company News

Ferrer, Fundacion Medina deal

...the University of Granada. Details were not disclosed. Grupo Ferrer Internacional S.A. , Barcelona, Spain Fundacion Medina...
Items per page:
1 - 6 of 6